Stabilization of motor nerve terminal membranes by insulin.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001692:Biological Transport; D002210:Caprylates / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects / Q000473:pathology; D002463:Cell Membrane Permeability / Q000187:drug effects; D003920:Diabetes Mellitus / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000378:metabolism* / Q000473:pathology; D005632:Fructose / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007328:Insulin / Q000009:adverse effects / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D008564:Membrane Potentials; D009046:Motor Neurons / Q000187:drug effects; D009469:Neuromuscular Junction / Q000378:metabolism*; D011188:Potassium / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000378:metabolism; D009435:Synaptic Transmission
D002210:Caprylates; D007328:Insulin; D005632:Fructose; D012964:Sodium; D005947:Glucose; D000109:Acetylcholine; D011188:Potassium